Tectonic Therapeutic (TECX) Cash from Investing Activities (2017 - 2026)
Tectonic Therapeutic (TECX) reported Cash from Investing Activities of -$19000.0 for Q1 2026, up 29.63% year-over-year from -$14657.1 in Q1 2025, and up 88.55% quarter-over-quarter from -$166000.0 in Q3 2025.
Tectonic Therapeutic (TECX) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Cash from Investing Activities data on file, last reported at -$19000.0 in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$19000.0, up 29.63% year-over-year; the trailing twelve-month figure through Mar 2026 was -$130000.0 (up 27.37% YoY), and the FY2025 annual result was -$138000.0, up 11.54% from the prior year.
- Cash from Investing Activities climbed to -$19000.0 in Q1 2026 per TECX's latest filing, from -$166000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $55000.0 in Q2 2025 and troughed at -$214000.0 in Q2 2023.
- A 5-year average of -$57266.7 and a median of -$27000.0 in 2025 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities tumbled 2085.71% in 2024, then soared 1275.0% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at -$86000.0 in 2022, then jumped by 41.86% to -$50000.0 in 2023, then surged by 94.0% to -$3000.0 in 2024, then slumped by 5433.33% to -$166000.0 in 2025, then jumped by 88.55% to -$19000.0 in 2026.
- Business Quant data shows TECX's Cash from Investing Activities at -$19000.0 in Q1 2026, -$166000.0 in Q3 2025, and $55000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -2.89 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 638.50 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -431.90 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 579,519.10 |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | -19,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19,000.00 |
| Mar 31, 2026 | -19,000.00 |
| Sep 30, 2025 | -166,000.00 |
| Sep 30, 2025 | -166,000.00 |
| Jun 30, 2025 | 55,000.00 |
| Jun 30, 2025 | 55,000.00 |
| Mar 31, 2025 | -27,000.00 |
| Mar 31, 2025 | -27,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Sep 30, 2024 | -153,000.00 |
| Sep 30, 2024 | -153,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Dec 31, 2023 | -50,000.00 |
| Dec 31, 2023 | -50,000.00 |
| Sep 30, 2023 | -7,000.00 |
| Sep 30, 2023 | -7,000.00 |